Skip to content

New Feature Updates

New Feature Updates

It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users.  Those are the customizable consent and confirmation page features that can be enabled. Read below to see how you can use these features to make sure all patients are ready to go prior to your appointments and key information is reinforced, reducing time costly omissions.

Customize Your Consents

If you wish to create your own consents and make them part of your intake forms, we now have an easier process to do so. 

When logged in, hover over your settings and select the ‘Patient Portal’ setting.

Once there, turn the ‘Custom Consent’ to ‘Yes’ and a label and text box will appear.  Here you can enter the text that you require patients to sign. 

If you have more than one consent that you require, select the + button to the right of the text box to generate a new label and box.  When you are done, hit the ‘Update’ button.  The consent(s) will now be live on your intake forms and will be time-stamped, signed, and stored with the medical record.

Customize Your Intake Confirmation Page

If you want to remind patients of what to bring to an appointment, direct them to state registries, or simply just list your location again, we now have an easy way to do so with our ‘Directory Profile’ setting.

Once logged in, hover over Settings and select ‘Directory Profile’. 

Scroll down to the text box labeled ‘Thank You Page Text’ and type or paste your customized message.  The box accepts html so you can customize its content and appearance even more. Once you are done, select ‘Update’ and your new ‘Confirmation/Thank You’ page will be displayed after a patient completes the intake form.

Stories you may be interested in

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More

Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois

ABSTRACT Objectives To assess health-related outcomes associated with medical cannabis use among older patients in Colorado and Illinois enrolled in their home state’s medical cannabis program. Methods Cross-sectional data from anonymous surveys were collected from 139 persons over the age of 60 using medical cannabis in the past year. We used structural equation modeling (SEM)…
Read More

CEO Spotlight: James West

As a former academic coordinator for the City University of New York Research Foundation and Medgar Evers College, CEO and co-founder of Arfinn Med, James West, has extensive experience in adult education and professional training programming. James put this extensive education to good use when he noticed that there was a direct need for a…
Read More

Medical Marijuana Faces Acceptance Barrier by Hesitant Medical Schools

A new study shows a growing interest by university pharmacy programs in teaching about medical marijuana in their curriculum, while medical schools seem to lag behind. Sixty-two percent of U.S. pharmacy school respondents queried in a new survey said they included medical marijuana in their doctorate of pharmacy curriculum. That’s according to a nine-page study co-authored by…
Read More

Colorado looks to medical marijuana to ease opioid crisis

As the nation grapples with an opioid crisis that kills more than 130 people every day, Colorado thinks a solution may lie in a joint, a vape pen or a topical. On Friday, it becomes the third state in the nation after New York and Illinois to allow doctors to recommend medical marijuana for any condition…
Read More

Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says

Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020. Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber…
Read More

Leave a Comment

You must be logged in to post a comment.